Indianapolis-based Carnyx says its oral drug boosted NREM sleep in aged animals, and it has hired Chris Brearley as chief ...

Arrowhead says its RNAi drug crossed the blood-brain barrier in healthy volunteers and sharply lowered tau, a protein tied to Alzheimer’s.

GlobalData says more adults with type 2 diabetes in England hit blood sugar and weight targets on tirzepatide than on ...

A new review argues postpartum recovery may shape lifelong aging; a fandom health standard asks who helps mothers get there.

INmune Bio is pairing a quantum machine with AI to find diseases beyond Alzheimer’s that its drug candidate might help.

Berlin keynote details Eos SENOLYTIX's pre-clinical results with mitochondrial-targeted geropeptide on healthspan and lifespan.

KAUST and Oxford researchers used a transistor-based sensor to read three forms of alpha-synuclein, reaching 90.9% accuracy ...

Cognition Therapeutics wins a US patent on a new crystal form of zervimesine and has an FDA meeting on its Lewy body trial ...

TimePie's Hebe Chen spotlights key developments from Shanghai, from therapeutic targets to China’s expanding clinical ...

Immorta Bio says its AI-designed SenoMune-0257 prompts T cells to clear senescent cells, and plans first human evaluation ...

A two-year partnership with Ultrahuman aims to connect clinical biomarkers and wearable data, bringing aging assessment into ...

Shmouni and Koehl Robinson unpack peptide medicine, from GLP-1s and BPC-157 to evidence, safety, regulation and personalized ...